Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Power to the Patients

Apr 09 2025 | 00:40:32

00:00 / 00:40:32

Show Notes

In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and depression. They highlight the importance of holistic care, digital therapeutics, and industry collaboration to address unmet needs and improve outcomes in mental health.

Other Episodes

Episode 3

October 03, 2024 • 00:41:13

The Mental Health Epidemic in Rural America

In this episode, we sit down with Jeff Winton, Founder and Chairman of Rural Minds, a nonprofit dedicated to advocating for mental health services...

Episode 15

March 07, 2025 • 01:01:02

John Krystal: Advancing Ketamine Research & Psychiatry at Yale

John Krystal, Chair of the Department of Psychiatry at Yale, joins Brandon Li to discuss his groundbreaking work on ketamine's antidepressant effects and the...

Episode 1

September 19, 2024 • 00:38:43

Psychedelics and the Future of Anxiety Relief

In this episode, Dr. Dan Karlin, Chief Medical Officer at MindMed, talks about the potential of psychedelic therapies, especially LSD, to help treat anxiety....